Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-03

FDA Approved: ZOLMITRIPTAN — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA lists a supplemental approval for zolmitriptan from Ajanta Pharma USA Inc. under an ANDA, indicating the approval of a supplemental application for this gen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolmitriptan (generic) (zolmitriptan)

Snippet

SUPPL AP for ZOLMITRIPTAN (ZOLMITRIPTAN)